28987-49-7

Basic information

• Product Name: Benzene, 2-fluoro-1-nitro-4-propoxy-
• CAS NO: 28987-49-7
• Molecular Formula: C9H10FNO3
• Molecular Weight: 199.182
• Mol File: 28987-49-7.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: Benzene, 2-fluoro-1-nitro-4-propoxy-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzene, 2-fluoro-1-nitro-4-propoxy-(28987-49-7)
• EPA Substance Registry System: Benzene, 2-fluoro-1-nitro-4-propoxy-(28987-49-7)

Safety Data

• Hazardous Substances Data: 28987-49-7(Hazardous Substances Data)

Upstream product

• 394-41-2 3-fluoro-4-nitrophenol 
• 106-94-5 propyl bromide 
• 71-23-8 propan-1-ol 

Downstream Products

• 859877-40-0 N-methyl-2-nitro-5-propoxyaniline 
• 113501-99-8 2-nitro-5-propoxyaniline 
• 1446282-02-5 2-chloro-N-(2-nitro-5-propoxyphenyl)acetamide 
• 1446282-03-6 N-(2-nitro-5-propoxyphenyl)-2-piperidylacetamide 
• 1446282-04-7 N-(2-amino-5-propoxyphenyl)-2-piperidylacetamide 
• 1446282-05-8 N-(2-{[2-(2,6-dimethylphenoxy)ethyl]amino}-5-propoxyphenyl)-2-piperidylacetamide 
• 1446281-89-5 1-[2-(2,6-dimethylphenoxy)ethyl]-2-piperidin-1-ylmethyl-5-propoxy-1H-benzimidazole 

Relevant articles and documents

BENZIMIDAZOLE DERIVATIVES AS SELECTIVE BLOCKERS OF PERSISTENT SODIUM CURRENT

The present invention is directed to methods of treating diseases or conditions mediated by elevated persistent sodium channel, such as ocular disorders, pain, multiple sclerosis, and seizure disorders utilizing a compound of Formula I or a pharmaceutically acceptable salt thereof or a pharmaceutical composition comprising said compound, wherein variables R, R1, R2, R3, R4, R5, m, and n in Formula I are as defined herein